Disease: Triglycerides measurement
Source: GWASDB ×
Variant Gene DSI v DPI v Chr Position Consequence Alleles Class AF EXOME AF GENOME Num. diseases
rs629301
CELSR2
0.851 0.120 1 109275684 3 prime UTR variant G/T snv 0.74 8
rs11668477 0.925 0.080 19 11084354 downstream gene variant A/G snv 0.34 6
rs6511720
LDLR
0.790 0.120 19 11091630 intron variant G/T snv 0.12 10
rs12272004 1.000 0.040 11 116733008 TF binding site variant C/A snv 9.8E-02 3
rs964184
ZPR1
0.716 0.440 11 116778201 3 prime UTR variant G/C snv 0.82 12
rs6589566
ZPR1
0.882 0.080 11 116781707 intron variant G/A;C;T snv 7
rs1263173 0.925 0.080 11 116810292 downstream gene variant G/A snv 0.53 2
rs17321515 0.776 0.200 8 125474167 intron variant A/G snv 0.49 7
rs10401969
SUGP1
0.776 0.240 19 19296909 intron variant T/C snv 0.10 6
rs16996148 0.882 0.120 19 19547663 downstream gene variant G/T snv 0.10 5
rs328
LPL
0.732 0.440 8 19962213 stop gained C/G snv 9.2E-02 9.0E-02 7
rs12678919 0.882 0.080 8 19986711 intergenic variant A/G snv 1.0E-01 7
rs10503669 0.925 0.080 8 19990179 intergenic variant C/A snv 8.4E-02 7
rs2083637 0.925 0.080 8 20007664 intergenic variant A/G snv 0.25 6
rs6754295 1.000 0.040 2 20983311 regulatory region variant T/G snv 0.27 5
rs693
APOB
0.708 0.440 2 21009323 synonymous variant G/A snv 0.39 0.38 7
rs2144300
GALNT2
0.882 0.040 1 230159169 intron variant C/T snv 0.44 4
rs4846914
GALNT2
0.925 0.080 1 230159944 intron variant G/A snv 0.45 4
rs780094
GCKR
0.658 0.400 2 27518370 intron variant T/C snv 0.67 24
rs157580
TOMM40
0.882 0.160 19 44892009 intron variant G/A snv 0.69 11
rs2075650
TOMM40
0.662 0.360 19 44892362 intron variant A/G snv 0.13 0.13 20
rs4420638
APOC1
0.708 0.520 19 44919689 downstream gene variant A/G snv 0.18 15
rs7679
PCIF1
0.925 0.160 20 45947863 3 prime UTR variant T/C snv 0.13 6
rs9989419 0.882 0.120 16 56951227 regulatory region variant A/G snv 0.55 8
rs173539 0.882 0.080 16 56954132 intergenic variant C/T snv 0.33 7